Details for New Drug Application (NDA): 063294
✉ Email this page to a colleague
NDA 063294 describes CEFIZOX, which is a drug marketed by Astellas and is included in three NDAs. Additional details are available on the CEFIZOX profile page.
The generic ingredient in CEFIZOX is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
The generic ingredient in CEFIZOX is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
Summary for 063294
| Tradename: | CEFIZOX |
| Applicant: | Astellas |
| Ingredient: | ceftizoxime sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063294
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Mar 31, 1994 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Mar 31, 1994 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
